Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Sep 1;20(10):593. doi: 10.1038/s41577-020-00442-6

Immune correlates of SARS-CoV-2 protection

Matthew Brown 1,
PMCID: PMC7461747  PMID: 32873886

The protective potential of SARS-CoV-2 neutralizing antibodies (nAbs) has not been validated in humans. This preprint study analysed an outbreak on a fishing vessel (n = 122) with an infection rate of 85%. Before departure, all individuals with available data (n = 120) were negative for SARS-CoV-2 infection by RT-PCR but 6 were positive for IgG against viral nucleoprotein. Of the 6 seropositive individuals, 3 had antibodies to SARS-CoV-2 spike protein and its receptor-binding domain (RBD) that could both neutralize pseudotyped lentiviruses and block the interaction between the RBD and the virus entry receptor ACE2. These 3 individuals did not get infected, unlike the 103 individuals who lacked pre-existing nAbs, suggesting that nAb titres are a correlate of viral immunity and, potentially, vaccine efficacy.

Competing interests

The author declares no competing interests.

References

Original article

  1. Addetia A, et al. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate. medRxiv. 2020 doi: 10.1101/2020.08.13.20173161. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES